Compare CDNA & PMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDNA | PMT |
|---|---|---|
| Founded | 1998 | 2009 |
| Country | United States | United States |
| Employees | N/A | 7 |
| Industry | Medical Specialities | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 915.6M |
| IPO Year | 2007 | N/A |
| Metric | CDNA | PMT |
|---|---|---|
| Price | $21.60 | $10.53 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 5 |
| Target Price | ★ $28.00 | $13.50 |
| AVG Volume (30 Days) | 652.5K | ★ 975.2K |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 13.33% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $48,324,000.00 | N/A |
| Revenue This Year | $16.01 | N/A |
| Revenue Next Year | $11.31 | $1.55 |
| P/E Ratio | $429.80 | ★ $12.59 |
| Revenue Growth | ★ 18.93 | N/A |
| 52 Week Low | $10.96 | $10.23 |
| 52 Week High | $23.24 | $13.80 |
| Indicator | CDNA | PMT |
|---|---|---|
| Relative Strength Index (RSI) | 59.06 | 35.38 |
| Support Level | $15.80 | N/A |
| Resistance Level | $22.89 | $12.82 |
| Average True Range (ATR) | 1.00 | 0.28 |
| MACD | -0.06 | -0.05 |
| Stochastic Oscillator | 76.54 | 16.04 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
PennyMac Mortgage Investment Trust is a specialty finance company that invests mainly in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.